PDE5A and diabetic cardiomyopathy: Increases in LV EDV and LVID associated with improved diastolic function and stroke volume have been reported with PDE5 inhibitors in other patient populations, including heart failure with preserved ejection fraction [22] and diabetic cardiomyopathy [23].